We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 35 Manufacturers, Suppliers and Companies | IPROS GMS

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. Panorama Data Insights Ltd. Tokyo//Testing, Analysis and Measurement
  4. 4 大塚化学 Tokyo//Chemical
  5. 5 立山化成 Toyama//Manufacturing and processing contract
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

  1. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  2. Pharmaceutical CDMO services 大塚化学
  3. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成
  4. 4 Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  5. 4 [Research Material] The Global Market for Acetylsalicylic Acid マーケットリサーチセンター

medicine Product List

121～150 item / All 609 items

Displayed results
[Research Material] The Global Market for Zoonotic Disease Treatment

[Research Material] The Global Market for Zoonotic Disease Treatment

Global Market for Zoonotic Disease Treatment: Viral Hepatitis, Rabies, Relapsing Fever, Tuberculosis, Malaria, Hospitals, Clinics

This research report (Global Zoonotic Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for zoonotic disease treatment over the next five years. It includes information on the overview of the global zoonotic disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the zoonotic disease treatment market focus on viral hepatitis, rabies, relapsing fever, tuberculosis, and malaria, while the segments by application target hospitals and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for zoonotic disease treatment. It also includes the market share of major companies in zoonotic disease treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Schizophrenia Treatment

[Research Material] The Global Market for Schizophrenia Treatment

World Market for Schizophrenia Treatment: Atypical Antipsychotics, Phenothiazine Antipsychotics, Thioxanthene, Other Antipsychotics, Hospital Pharmacies, etc.

This research report (Global Schizophrenia Treatments Market) investigates and analyzes the current state and future outlook of the global market for schizophrenia treatments over the next five years. It includes information on the overview of the global schizophrenia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the schizophrenia treatment market include atypical antipsychotics, phenothiazine antipsychotics, thioxanthene, and other antipsychotics, while the segments by application cover hospital pharmacies, drugstores, retail pharmacies, and e-commerce. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for schizophrenia treatments. The report also includes the market share of major companies in schizophrenia treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Cytomegalovirus (CMV) Retinitis Treatment

[Research Material] Global Market for Cytomegalovirus (CMV) Retinitis Treatment

Global Market for Cytomegalovirus (CMV) Retinitis Treatment: Capsules, Solutions, Implants, Tablets, Hospitals, Outpatient Surgery Centers, Others

This research report (Global Cytomegalovirus Retinitis Treatment Market) investigates and analyzes the current state and outlook for the global market for cytomegalovirus (CMV) retinitis treatment over the next five years. It includes information on the overview of the global cytomegalovirus (CMV) retinitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for cytomegalovirus (CMV) retinitis treatment by type include capsules, solutions, implants, and tablets, while the segments by application focus on hospitals, outpatient surgery centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cytomegalovirus (CMV) retinitis treatment. It also includes the market share of major companies in the cytomegalovirus (CMV) retinitis treatment sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Age-related Macular Degeneration (AMD) Treatment

[Research Material] The Global Market for Age-related Macular Degeneration (AMD) Treatment

Global Market for Age-related Macular Degeneration (AMD) Treatment: Wet AMD, Dry AMD, Hospitals, Clinics, Research Institutions, Others

This research report (Global Age-Related Macular Degeneration (AMD) Ther) investigates and analyzes the current state and outlook for the global market for age-related macular degeneration (AMD) treatment over the next five years. It includes information on the global overview of the AMD treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the AMD treatment market focus on wet AMD and dry AMD, while the segments by application target hospitals, clinics, research institutions, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for AMD treatment. It also includes the market share of major companies in AMD treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Amyloidosis Treatment Drugs

[Research Material] The Global Market for Amyloidosis Treatment Drugs

World Market for Amyloidosis Treatments: AG-10, ALN-ANG, ALN-TTRsc02, CAEL-101, Canakinumab, etc.

This research report (Global Amyloidosis Therapeutics Market) investigates and analyzes the current state and outlook for the global market for amyloidosis therapeutics over the next five years. It includes information on the overview of the global amyloidosis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AG-10, ALN-ANG, ALN-TTRsc02, CAEL-101, Canakinumab, and others, while the segments by application cover AL amyloidosis, AA amyloidosis, ATTR amyloidosis, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for amyloidosis therapeutics. It also includes the market share of major companies in amyloidosis therapeutics, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Autism Treatment

[Research Material] The Global Market for Autism Treatment

Global Market for Autism Treatment: Serotonin Reuptake Inhibitors (SSRIs), Insomnia Medications, Anticonvulsants, Antipsychotics, Others, Hospital Pharmacies, Retail Pharmacies ...

This research report (Global Autism Treatment Market) investigates and analyzes the current state of the global autism treatment market and its outlook for the next five years. It includes information on the overview of the global autism treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the autism treatment market include serotonin reuptake inhibitors (SSRIs), insomnia medications, anticonvulsants, antipsychotics, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, online pharmacies, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for autism treatment. The report also includes the market share of major companies in autism treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Impetigo Treatment Drugs

[Research Material] Global Market for Impetigo Treatment Drugs

Global Market for Impetigo Treatment Drugs: FMX-102, LTX-109, Mupirocin, Ozenoxacin, Others, Clinics, Hospitals, Others

This research report (Global Impetigo Drug Market) investigates and analyzes the current status and outlook for the global market of impetigo treatment drugs over the next five years. It includes information on the global overview of the impetigo treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include FMX-102, LTX-109, mupirocin, ozenoxacin, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments calculate the market size of impetigo treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the impetigo treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Metabotropic Glutamate Receptor 3

[Research Material] Global Market for Metabotropic Glutamate Receptor 3

Global Market for Metabotropic Glutamate Receptor 3: LY-3020371, VU-0092273, DT-010991, Others, Autism, Chronic ...

This research report (Global Metabotropic Glutamate Receptor 3 Market) investigates and analyzes the current status and outlook for the global market of metabotropic glutamate receptor 3 over the next five years. It includes information on the overview of the global metabotropic glutamate receptor 3 market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include LY-3020371, VU-0092273, DT-010991, and others, while the segments by application focus on autism, chronic pain, glioma, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of metabotropic glutamate receptor 3. It also includes the market share of major companies in the metabotropic glutamate receptor 3 sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Gluten Intolerance Treatment

[Research Material] The Global Market for Gluten Intolerance Treatment

Global Market for Gluten Intolerance Treatment: Antihistamines, Epinephrine, Retail Pharmacies, Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies

This research report (Global Gluten Intolerance Treatment Market) investigates and analyzes the current state of the global market for gluten intolerance treatment and its outlook for the next five years. It includes information on the overview of the global gluten intolerance treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the gluten intolerance treatment market focus on antihistamines and epinephrine, while the segments by application target retail pharmacies, hospital pharmacies, specialty pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for gluten intolerance treatment. It also includes the market share of major companies in gluten intolerance treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Peptide Infectious Disease Therapeutics

[Research Material] Global Market for Peptide Infectious Disease Therapeutics

Global Market for Peptide Infection Treatment Drugs: Telaprevir, Sofosbuvir, Others, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Peptide Based Infection Therapeutics Market) investigates and analyzes the current state and outlook for the global market of peptide infection therapeutics over the next five years. It includes information on the overview of the global peptide infection therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Telaprevir, Sofosbuvir, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for peptide infection therapeutics. It also includes the market share of major companies in peptide infection therapeutics, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Autosomal Dominant Polycystic Kidney Disease

[Research Material] The Global Market for Treatment of Autosomal Dominant Polycystic Kidney Disease

Global Market for Treatment of Autosomal Dominant Polycystic Kidney Disease: Pain and Inflammation Treatment, Kidney Stone Treatment, Urinary Tract Infection Treatment, Renal Failure Treatment, Others, Hospitals, Clinics ...

This research report (Global Autosomal Dominant Polycystic Kidney Disease) investigates and analyzes the current status and outlook for the global market for autosomal dominant polycystic kidney disease treatment over the next five years. It includes information on the overview of the global autosomal dominant polycystic kidney disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include pain and inflammation treatment, kidney stone treatment, urinary tract infection treatment, renal failure treatment, and others, while the segments by application include hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for autosomal dominant polycystic kidney disease treatment. It also includes the market share of major companies in the autosomal dominant polycystic kidney disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Renal Anemia Treatment

[Research Material] The Global Market for Renal Anemia Treatment

Global Market for Renal Anemia Treatment: Iron Supplements, Erythropoiesis-Stimulating Agents, Hospitals, Pharmacies, Research Institutions, Others

This research report (Global Renal Anemia Treatment Market) investigates and analyzes the current status and outlook for the global renal anemia treatment market over the next five years. It includes information on the overview of the global renal anemia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the renal anemia treatment market focus on iron supplements and erythropoiesis-stimulating agents, while the segments by application target hospitals, pharmacies, research institutions, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for renal anemia treatment. It also includes the market share of major companies in renal anemia treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Cystic Acne Treatment

[Research Material] The Global Market for Cystic Acne Treatment

World Market for Cystic Acne Treatment: Topical Medications, Laser Treatments, Microdermabrasion, Others, Hospitals, Clinics, Others

This research report (Global Cystic Acne Treatment Market) investigates and analyzes the current status and outlook for the global market for cystic acne treatment over the next five years. It includes information on the overview of the global cystic acne treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cystic acne treatment market include topical medications, laser treatments, microdermabrasion, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cystic acne treatment. It also includes the market share of major companies in cystic acne treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hepatitis Treatment Drugs

[Research Material] Global Market for Hepatitis Treatment Drugs

World Market for Hepatitis Treatment Drugs: VEMLIDY, EPCLUSA, SOVALDI, INCIVEK, OLYSIO, VICTRELIS, ...

This research report (Global Hepatitis Drugs Market) investigates and analyzes the current state and outlook for the global hepatitis treatment drug market over the next five years. It includes information on the overview of the global hepatitis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include VEMLIDY, EPCLUSA, SOVALDI, INCIVEK, OLYSIO, VICTRELIS, VIREAD, HEPSERA, BARACLUDE, and TYZEKA, while the segments by application focus on hepatitis A, B, C, D, and E. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for hepatitis treatment drugs. The report also includes the market share of major companies in the hepatitis treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Mefenamic Acid

[Research Material] The Global Market for Mefenamic Acid

World Market for Mefenamic Acid: Patents, Generics, Hospitals, Drugstores, Online

This research report (Global Mefenamic Acid Market) investigates and analyzes the current state of the global mefenamic acid market and its outlook for the next five years. It includes information on the overview of the global mefenamic acid market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the mefenamic acid market focus on patented and generic products, while the segments by application target hospitals, drugstores, and online sales. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of mefenamic acid. It also includes the market share of major companies in the mefenamic acid sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Prescription Dermatological Treatments

[Research Material] The Global Market for Prescription Dermatological Treatments

Global Market for Prescription Dermatological Treatments: Antifungal Drugs, Skin Cancer Drugs, Acne & Rosacea Drugs, Psoriasis Drugs, Dermatitis & Seborrheic Drugs, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Prescription Dermatology Therapeutics Market) investigates and analyzes the current state and outlook for the global prescription dermatology therapeutics market over the next five years. It includes information on the overview of the global prescription dermatology therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the prescription dermatology therapeutics market include antifungal medications, skin cancer drugs, acne & rosacea medications, psoriasis treatments, and dermatitis & seborrheic dermatitis medications. The segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for prescription dermatology therapeutics. It also includes the market share of major companies in prescription dermatology therapeutics, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Tourette Syndrome Treatment Drugs

[Research Material] Global Market for Tourette Syndrome Treatment Drugs

World Market for Tourette Syndrome Treatments: AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipa ...

This research report (Global Tourette Syndrome Drug Market) investigates and analyzes the current state and future outlook of the global market for Tourette syndrome treatment drugs over the next five years. It includes information on the overview of the global Tourette syndrome treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipam Hydrochloride, and Others, while the segments by application focus on research centers, hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Tourette syndrome treatment drugs. The report also includes the market share of major companies in the Tourette syndrome treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Cushing's Syndrome Treatment

[Research Material] The Global Market for Cushing's Syndrome Treatment

World Market for Cushing's Syndrome Treatment: Glucocorticoid Receptor Inhibitors, Somatostatin, Ketoconazole HRA, Others, Hospital Pharmacies, Small ...

This research report (Global Cushing's Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global market for Cushing's syndrome treatment over the next five years. It includes information on the overview of the global Cushing's syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Cushing's syndrome treatment market include glucocorticoid receptor antagonists, somatostatin, ketoconazole HRA, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Cushing's syndrome treatment. It also includes the market share of major companies in the Cushing's syndrome treatment sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Trigeminal Neuralgia Treatment Drugs

[Research Material] Global Market for Trigeminal Neuralgia Treatment Drugs

Global Market for Trigeminal Neuralgia Treatment Drugs: Carbamazepine, Oxcarbazepine, Others, Hospitals, Clinics, Others

This research report (Global Trigeminal Neuralgia Treatment Medicine Market) investigates and analyzes the current status and outlook for the global market for trigeminal neuralgia treatment medications over the next five years. It includes information on the overview of the global trigeminal neuralgia treatment medication market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include carbamazepine, oxcarbazepine, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for trigeminal neuralgia treatment medications. It also includes the market share of major companies in the trigeminal neuralgia treatment medication sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for mRNA Vaccines and Therapeutics

[Research Material] Global Market for mRNA Vaccines and Therapeutics

Global Market for mRNA Vaccines and Therapeutics: Infectious Disease Vaccines, Cancer Vaccines, Infectious Diseases, Cancer, Others

This research report (Global mRNA Vaccines & Therapeutics Market) investigates and analyzes the current state and future outlook of the global mRNA vaccine and therapeutic market over the next five years. It includes information on the overview of the global mRNA vaccine and therapeutic market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on infectious disease vaccines and cancer vaccines, while the segments by application target infectious diseases, cancer, and others. The regional segments calculate the market size of mRNA vaccines and therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the mRNA vaccine and therapeutic market, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Materials] Global Market for Treatment Drugs for Muscular Dystrophy

[Research Materials] Global Market for Treatment Drugs for Muscular Dystrophy

Global Market for Treatment Drugs for Myotonic Dystrophy: ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others...

This research report (Global Myotonic Dystrophy Drug Market) investigates and analyzes the current state and outlook for the global market for myotonic dystrophy treatments over the next five years. It includes information on the overview of the global myotonic dystrophy drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type include ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others, while the segments by application focus on hospitals, clinics, home care, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for myotonic dystrophy treatments. It also includes the market share of major companies in the myotonic dystrophy drug market, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Disease Treatments

[Research Material] Global Market for Rare Disease Treatments

Global Market for Rare Disease Treatments: Originator Drugs, Generic Drugs, Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies

This research report (Global Rare Disease Treatment Market) investigates and analyzes the current state of the global market for rare disease treatments and its outlook for the next five years. It includes information on the overview of the global rare disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare disease treatment market focus on originator drugs and generic drugs, while the segments by application target hospital pharmacies, specialty pharmacies, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for rare disease treatments. It also includes the market share of major companies in the rare disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Autoimmune Hepatitis Treatment

[Research Material] Global Market for Autoimmune Hepatitis Treatment

Global Market for Autoimmune Hepatitis Treatment: Tablets, Injections, Others, Hospitals, Clinics, Others

This research report (Global Autoimmune Hepatitis Treatment Market) investigates and analyzes the current status and outlook for the global autoimmune hepatitis treatment market over the next five years. It includes information on the overview of the global autoimmune hepatitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by key regions, and distribution channel analysis. The segments of the autoimmune hepatitis treatment market by type include tablets, injectables, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for autoimmune hepatitis treatment. It also includes the market share of major companies in autoimmune hepatitis treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

World Market for Oropharyngeal Cancer Treatments: BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others...

This research report (Global Nasopharyngeal Cancer Drug Market) investigates and analyzes the current status and outlook for the global market of nasopharyngeal cancer treatments over the next five years. It includes information on the overview of the global nasopharyngeal cancer drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for nasopharyngeal cancer treatments. It also includes the market share of major companies in the nasopharyngeal cancer drug market, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Epidermolysis Bullosa Treatment Drugs

[Research Material] Global Market for Epidermolysis Bullosa Treatment Drugs

Global Market for Epidermolysis Bullosa Treatment Drugs: EB-201, FCX-007, ICX-RHY, INM-750, Others, Clinics, Hospitals, Others

This research report (Global Epidermolysis Bullosa Therapeutics Market) investigates and analyzes the current status and future outlook of the global market for epidermolysis bullosa therapeutics over the next five years. It includes information on the overview of the global epidermolysis bullosa therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include EB-201, FCX-007, ICX-RHY, INM-750, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for epidermolysis bullosa therapeutics. It also includes the market share of major companies in the epidermolysis bullosa therapeutics sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Materials] Global Market for Purpura Treatment Drugs

[Research Materials] Global Market for Purpura Treatment Drugs

World Market for Purpura Treatments: Allergic Purpura, Thrombocytopenic Purpura, Hospital Use, Clinic Use, Home Use, Others

This research report (Global Purpura Therapy Drugs Market) investigates and analyzes the current status and outlook for the global market of purpura treatment drugs over the next five years. It includes information on the overview of the global purpura treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on allergic purpura and thrombocytopenic purpura, while the segments by application target hospitals, clinics, home use, and others. The regional segments calculate the market size of purpura treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in purpura treatment drugs, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Knee Treatment in Athletes

[Research Material] Global Market for Knee Treatment in Athletes

World Market for Athlete Knee Treatments: Corticosteroids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Hyaluronic Acid, Others, Hospitals, Clinics ...

This research report (Global Athletic Knee Treatment Market) investigates and analyzes the current state and outlook for the global market for athlete knee treatments over the next five years. It includes information on the overview of the global athlete knee treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), hyaluronic acid, and others, while the segments by application cover hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for athlete knee treatments. It also includes the market share of major companies in athlete knee treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rheumatic Disease Therapeutics

[Research Material] Global Market for Rheumatic Disease Therapeutics

World Market for Rheumatic Disease Therapeutics: Tumor Necrosis Factor-α Inhibitors, Interleukin and Interleukin Receptor Inhibitors, Protein Kinase ...

This research report (Global Rheumatic Disorders Drug Market) investigates and analyzes the current state and outlook for the global market for rheumatic disease treatment drugs over the next five years. It includes information on the overview of the global rheumatic disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rheumatic disease treatment drug market include tumor necrosis factor-alpha inhibitors, interleukin and interleukin receptor inhibitors, protein kinase inhibitors, cell surface antigen inhibitors, hormone and hormone receptor inhibitors, and others. The segments by application include rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, psoriatic arthritis, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for rheumatic disease treatment drugs. It also includes the market share of major companies in the rheumatic disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Treatment Drugs for Undifferentiated Large Cell Lymphoma

[Research Document] Global Market for Treatment Drugs for Undifferentiated Large Cell Lymphoma

World Market for Undifferentiated Large Cell Lymphoma Treatment Drugs: Oral, Injection, Hospitals, Drugstores, Others

This research report (Global Anaplastic Large Cell Lymphoma Drugs Market) investigates and analyzes the current status and outlook for the global market of anaplastic large cell lymphoma treatment drugs over the next five years. It includes information on the overview of the global anaplastic large cell lymphoma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type focus on oral and injectable forms, while the segments by application target hospitals, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for anaplastic large cell lymphoma treatment drugs. It also includes the market share of major companies in the anaplastic large cell lymphoma treatment drugs sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Primary Sclerosing Cholangitis Treatment

[Research Material] Global Market for Primary Sclerosing Cholangitis Treatment

Global Market for Primary Sclerosing Cholangitis Treatment: Liver Transplant Surgery, UDCA Drugs, PSC Drugs, Hospitals, Clinics, Others

This research report (Global Primary Sclerosing Cholangitis Treatment Market) investigates and analyzes the current state and outlook for the global market for primary sclerosing cholangitis treatment over the next five years. It includes information on the overview of the global primary sclerosing cholangitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the primary sclerosing cholangitis treatment market focus on liver transplant surgery, UDCA drugs, and PSC drugs, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for primary sclerosing cholangitis treatment. It also includes the market share of major companies in primary sclerosing cholangitis treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.